Work

Work

Engagements are scoped tightly and priced up front. Below is what each kind of work involves, followed by three examples of how it played out in practice.

  1. 01

    Inspection readiness

    Pre-approval, pre-license, for-cause and surveillance. I prepare sites the way an investigator would assess them, because that is the job I used to do.

    Mock inspections run at real intensity, SME preparation and storyboarding, front-room and back-room design, and an honest read on what an investigator would find in the first two hours. The deliverable is a ranked gap list with owners and dates, not a reassurance exercise.

    • Mock PAI, PLI and for-cause inspections
    • SME coaching and storyboard development
    • Facility and document-room readiness review
  2. 02

    Quality systems & remediation

    Building a quality system that scales, or repairing one that has already attracted attention.

    Investigations, CAPA, change control, document management and data integrity — designed to the toughest standard that applies to you, then localised for individual markets. Where there is already a 483 or a warning letter, I help write responses that commit to what you can actually deliver and then hold the remediation to its dates.

    • QMS design, harmonisation and gap assessment
    • 483 and warning-letter response strategy
    • Data integrity programmes and controls
  3. 03

    CDMO & supplier oversight

    Knowing what your contract manufacturer is actually doing, and being able to show that you knew.

    Risk-based supplier qualification, on-site and remote audits, and deficiency registers that track findings to closure. Sponsors remain accountable for what their contract sites do; the quality agreement describes the intent, and the audit establishes the fact.

    • Risk-based supplier qualification programmes
    • CDMO audits and deficiency registers
    • Site-to-scope responsibility mapping

Selected engagements

Three examples

Client names are withheld where the work is commercially sensitive. Happy to talk through any of these in more detail.

Cell & gene therapy sponsor

Advanced therapy · preparing a first licence application

Challenge

A sponsor approaching its first biologics licence application and pre-license inspection, with manufacturing split across contract sites and no consolidated view of CMC risk.

Approach

Built a deficiency register covering drug substance and drug product, mapped every item to the governing CFR, ICH and EU GMP requirement, then ran mock inspections against the gaps rather than against a checklist.

Outcome

A single ranked risk picture the sponsor could work through by owner and date, and SMEs who had already answered the hard questions once before an investigator asked them.

Contract manufacturing network

Biologics CDMO oversight · multi-site

Challenge

Quality agreements described the intent of the relationship, but nobody could demonstrate which party actually performed which GMP activity at which site.

Approach

Produced a site-to-scope responsibility map, ran audits built around probing questions tied to that map, and tracked each finding to documented closure.

Outcome

Defensible evidence of supplier oversight, and several responsibility gaps closed before a regulator could find them.

Post-merger pharmaceutical organisation

Generics and branded pharma · corporate QMS

Challenge

Two merged organisations running parallel quality systems, with more than 500 overlapping procedures and no single standard.

Approach

Led corporate-wide harmonisation: one global system for investigations, CAPA, change control, training and document control, with local annexes for market-specific requirements.

Outcome

A single integrated quality system across the combined organisation, built to the strictest applicable standard rather than the lowest common denominator.

Want to talk about a specific problem?

Tell me what is going wrong and what you have already tried. I will tell you honestly whether this is work I can help with.